ConductScience.org, home

Gene · 4593

Papers3,141

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 3,141

Download this page as JSON
TitleJournalYearPMIDFound bySource
Neuromuscular Mechanisms and Oxidative Stress in Skeletal Muscle Atrophy: Emerging Stem Cell and Gene-Based Therapeutic Strategies.Muscles202641718080PubTator, text miningPubMed
Anti-cancer effect of palmitic acid against the endometrial cancer progression via inducing ferroptosis.Biochem Biophys Rep202641717082PubTator, text miningPubMed
Cord serum metabolic signatures associated with neonatal anthropometry and neurodevelopment through age two in twins.iScience202641717000PubTator, text miningPubMed
The role and mechanism of IL‑35 in myasthenia gravis (Review).Int J Mol Med202641716022PubTator, text miningPubMed
A Case Report of Guillain-Barré Syndrome Presenting as Facial Diplegia: A Deviation From the Classical Ascending Paralysis.Cureus202641710842PubTator, text miningPubMed
Case Report: Immunotherapy-induced myocarditis requiring pacemaker insertion in an older adult. what happens if we rechallenge?Front Oncol202641710664PubTator, text miningPubMed
Successful Plasma Exchange and Steroid Maintenance Therapy for Severe Pembrolizumab-Induced Polyradiculoneuritis in Lung Cancer: A Case Report.Case Rep Oncol202641710645PubTator, text miningPubMed
Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study.J Neurol202641699286PubTator, text miningPubMed
Longitudinal MuSK antibody levels may correlate with disease severity in MuSK myasthenia gravis.J Neuroimmunol202641653839PubTator, text miningPubMed
Delayed recovery following myasthenic exacerbation and subsequent endplate-protecting treatment.Neurol Sci202641634421PubTator, text miningPubMed
PGVDA: a pathway-aggregated genetic dosage framework for interpretable disease classification using machine learning.Brief Bioinform202641632594PubTator, text miningPubMed
[Myasthenic syndromes: retrospective analysis of two patient cohorts].Fortschr Neurol Psychiatr202641628617PubTator, text miningPubMed
Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions.Mol Diagn Ther202641619083PubTator, text miningPubMed
Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer.Pharmacol Res Perspect202641582708PubTator, text miningPubMed
A Validated Transcriptomic NMJ Remodeling Score Reveals Synaptic Dysfunction Independent of Muscle Atrophy after Immobilization in a Microgravity Analog.Neuroinformatics202641579264PubTator, text miningPubMed
Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkers.J Neurol202641575592PubTator, text miningPubMed
Antibodies to watch in 2026.MAbs202641560619PubTator, text miningPubMed
CAR-T cell therapy: A new dawn in the treatment of autoimmune disease.Cell Transplant202641558532PubTator, text miningPubMed
Fiber-type-specific architecture and pathophysiology of the neuromuscular junction.Neuroscience202641548740PubTator, text miningPubMed
Co-Occurrence of Myasthenia Gravis and Facioscapulohumeral Muscular Dystrophy: A Case Series and Review of Literature.Eur J Neurol202641542987PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4593/papers?page=5